Junli Deng

No.127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Mutational landscape and risk estimates of DDR genes in Chinese ovarian cancer patients.

Mutational landscape and risk estimates of DDR genes in Chinese ovarian cancer patients.

Journal: Journal of ovarian research
Published: July 02, 2025

Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01).

Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01).

Journal: Annals of translational medicine
Published: October 12, 2022

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.

Journal: BMC cancer
Published: March 22, 2019

Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.

Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.

Journal: Expert review of proteomics
Published: September 07, 2016

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

Journal: Oncotarget
Published: September 02, 2016

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.

Journal: Oncotarget
Published: February 11, 2016

Cancer stem cells and signaling pathways in radioresistance.

Cancer stem cells and signaling pathways in radioresistance.

Journal: Oncotarget
Published: October 13, 2015

The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.

The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.

Journal: Cancer metastasis reviews
Published: April 24, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026